Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Biomerica Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q4 2021
- Shares held
- 2.52M
- +130.8K (+5.5%) vs. Q4 2021
- Total value
- $11.3M
- +$1.97M (+21.2%) vs. Q4 2021
- New holders
- 4
- 8 more added
- Sold out
- 0
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Granahan Investment Management Inc | 1,169,841 | $5.23M | 0.13% | +67,268+6.1% | Added |
| Vanguard Group Inc | 545,951 | $2.44M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 183,925 | $821.0K | 0.00% | +1,414+0.8% | Added |
| Fore Capital, LLC | 85,000 | $380.0K | 0.45% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 77,249 | $345.0K | 0.00% | +3,179+4.3% | Added |
| Heritage Investors Management Corp | 69,350 | $310.0K | 0.01% | 00.0% | Unchanged |
| Ridgewood Investments LLC | 60,000 | $268.0K | 0.18% | +60,000 | New |
| State Street Corp | 55,831 | $250.0K | 0.00% | +1,200+2.2% | Added |
| GWM Advisors LLC | 32,900 | $147.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 32,810 | $147.0K | 0.00% | +32,810 | New |
| Perritt Capital Management Inc | 30,000 | $134.0K | 0.07% | 00.0% | Unchanged |
| Group One Trading, L.P. | 27,432 | $123.0K | 0.00% | −45,400−62.3% | Reduced |
| Dimensional Fund Advisors LP | 26,463 | $118.0K | 0.00% | 00.0% | Unchanged |
| Emerald Advisers, LLC | 19,000 | $85.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 18,391 | $82.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 13,662 | $61.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,812 | $57.0K | 0.00% | +12,812 | New |
| Orion Capital Management LLC | 11,500 | $51.0K | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,500 | $47.0K | 0.00% | −3,711−26.1% | Reduced |
| HCR Wealth Advisors | 10,000 | $45.0K | 0.01% | −10,000−50.0% | Reduced |
| Simplex Trading, LLC | 9,091 | $40.0K | 0.00% | +9,091 | New |
| Wells Fargo & Company | 6,566 | $29.0K | 0.00% | +20.0% | Added |
| Bank of America Corp | 5,000 | $22.0K | 0.00% | +968+24.0% | Added |
| Morgan Stanley | 2,517 | $12.0K | 0.00% | +387+18.2% | Added |
| UBS Group AG | 2,415 | $11.0K | 0.00% | +1,027+74.0% | Added |
| Tower Research Capital LLC (TRC) | 1,308 | $6.00K | 0.00% | −203−13.4% | Reduced |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Ahrens Investment Partners LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |